β-Tubulin mutational analysis: Tantalizing findings [2]

Lung Cancer

Volumn 38, Issue 1, 2002, Pages 99-100

  Rosell, Rafael ^a   Tarón, Miquel ^a   Sarries, Carme ^a   Queralt, Cristina ^a   Roig, Barbara ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA TUBULIN; PACLITAXEL;

ACETYLATION; CANCER CELL CULTURE; CANCER RESISTANCE; CANCER STAGING; CODON; DNA POLYMORPHISM; DNA REPAIR; DNA TRANSPOSITION; GENE CONTROL; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; LETTER; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY CARCINOMA; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSEUDOGENE;

ANTINEOPLASTIC AGENTS; BRIDGED COMPOUNDS; CARCINOMA, NON-SMALL-CELL LUNG; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, NEOPLASM; HUMANS; LUNG NEOPLASMS; MICROTUBULES; POLYMORPHISM, GENETIC; TAXOIDS; TUBULIN; TUMOR CELLS, CULTURED;

EID: 0036806571     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(02)00188-5     Document Type: Letter

References (10)

1. Giannakakou P., Gussio R., Nogales E., et al. A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells. Proc. Natl. Acad. Sci. USA. 97:2000;2904-2909.
2. Tsurutani J., Komiya T., Uejima H., et al. Mutational analysis of the β-tubulin gene in lung cancer. Lung Cancer. 35:2002;11-16.
3. Kelley M.J., Li S., Harpole D.H. Genetic analysis of the β-tubulin gene, TUBB, in non-small-cell lung-cancer. J. Natl. Cancer Inst. 93:2001;1886-1888.
4. Monzó M., Rosell R., Sánchez J.J., et al. Paclitaxel resistance in non-small-cell lung cancer associated with beta-tubulin gene mutations. J. Clin. Oncol. 17:1999;1786-1793.
5. González-Garay M.L., Chang L., Blade K., Menick D.R., Cabral F. A β-tubulin leucine cluster involved in microtubule assembly and paclitaxel resistance. J. Biol. Chem. 274:1999;23875-23882.
6. Sale S., Sung R., Shen P., et al. Conservation of the class β-tubulin gene in human populations and lack of mutations in lung cancers and paclitaxel-resistant ovarian cancers. Mol. Cancer Ther. 1:2002;215-225.
7. He L., Huang Yang Ch.-P., Horwitz S.B. Mutations in β-tubulin map to domains involved in regulation of microtubule stability in epothilone-resistant cell lines. Mol. Cancer Ther. 1:2001;3-10.
8. Fujii G.H., Morimoto A.M., Berson A.E., Bolen J.B. Transcriptional analysis of the PTEN/MMAC1 pseudogene, ψPTEN. Oncogene. 18:1999;1765-1769.
9. Yarden R.I., Pardo-Reoyo S., Sgagias M., Cowan K.H., Brody L.C. BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nature Genet. 30:2002;285-289.
10. Giannakakou P., Poy G., Zhan Z., Knutsen T., Blagosklonny M.V., Fojo T. Paclitaxel selects for mutant or pseudo-null p53 in drug resistance associated with tubulin mutations in human cancer. Oncogene. 19:2000;3078-3085.